Literature DB >> 8548704

Mobilizing physicians to conduct clinical intervention in tobacco use through a medical-association program: 5 years' experience in British Columbia.

F Bass1.   

Abstract

During the last 5 years, a program run by the medical association in British Columbia has recruited 23% of the province's general practitioners (GPs) to take an active, systematic approach to clinical intervention in tobacco use. Another 9% of GPs (considered "semi-active") regularly use the program's educational materials for patients, and another 25% have been trained in intervention or have been given intervention materials or both. If the cessation rate (rate of patients who quit smoking who would not otherwise have done so) was 4% among physicians actively involved in intervention and 2% among physicians considered semi-active, in 1995 an estimated 4700 smokers quit and were followed by their GPs as a result of the program. Another 135,000 smokers received brief counselling from their GPs and were also followed. This article reviews the strategies and methods used in this program to mobilize physicians.

Entities:  

Mesh:

Year:  1996        PMID: 8548704      PMCID: PMC1488125     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  9 in total

1.  Staff involvement and special follow-up time increase physicians' counseling about smoking cessation: a controlled trial.

Authors:  C Duncan; M J Stein; S R Cummings
Journal:  Am J Public Health       Date:  1991-07       Impact factor: 9.308

2.  Smokers' preferences for assistance with cessation.

Authors:  N Owen; M J Davies
Journal:  Prev Med       Date:  1990-07       Impact factor: 4.018

3.  Clinical interventions in tobacco control. A National Cancer Institute training program for physicians.

Authors:  M Manley; R P Epps; C Husten; T Glynn; D Shopland
Journal:  JAMA       Date:  1991-12-11       Impact factor: 56.272

4.  Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials.

Authors:  T E Kottke; R N Battista; G H DeFriese; M L Brekke
Journal:  JAMA       Date:  1988-05-20       Impact factor: 56.272

5.  Smoking cessation treatment and the good doctor club.

Authors:  M C Fiore; T B Baker
Journal:  Am J Public Health       Date:  1995-02       Impact factor: 9.308

6.  Changing physician performance. A systematic review of the effect of continuing medical education strategies.

Authors:  D A Davis; M A Thomson; A D Oxman; R B Haynes
Journal:  JAMA       Date:  1995-09-06       Impact factor: 56.272

7.  How effective is nicotine replacement therapy in helping people to stop smoking?

Authors:  J L Tang; M Law; N Wald
Journal:  BMJ       Date:  1994-01-01

8.  Patients' perspectives of a physician-delivered smoking cessation intervention.

Authors:  D G Willms; J A Best; D M Wilson; J R Gilbert; D W Taylor; E Lindsay; J Singer; N A Johnson
Journal:  Am J Prev Med       Date:  1991 Mar-Apr       Impact factor: 5.043

9.  Effect of general practitioners' advice against smoking.

Authors:  M A Russell; C Wilson; C Taylor; C D Baker
Journal:  Br Med J       Date:  1979-07-28
  9 in total
  3 in total

1.  Physicians Taking Action Against Smoking: an intervention program to optimize smoking cessation counselling by Montreal general practitioners.

Authors:  M Tremblay; A Gervais; C Lacroix; J O'Loughlin; H Makni; G Paradis
Journal:  CMAJ       Date:  2001-09-04       Impact factor: 8.262

2.  Smoking cessation, physicians, and medical office staff. Clinical tobacco intervention in Prince Edward Island.

Authors:  M S Rowan; R B Coambs; P Jensen; M Balderston; D MacKenzie; A Kothari
Journal:  Can Fam Physician       Date:  1998-11       Impact factor: 3.275

3.  Assessment of tobacco control advocacy behavioural capacity among students at schools of public health in China.

Authors:  Tingzhong Yang; Abu S Abdullah; Ian R H Rockett; Mu Li; Yuhua Zhou; Jun Ma; Huaping Ji; Jianzhong Zheng; Yuhong Zhang; Liming Wang
Journal:  Tob Control       Date:  2010-09-21       Impact factor: 7.552

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.